Breaking News, Business, Financial and Economic News, World News from EconoTimes

Become a contributor

Bookmark Econotimes

Thu, May 01, 2025 11:40 PM All times are UTC

Follow Series

©Econometrics LLC 2025. All Rights Reserved.

Sydney Rosen

Professor of Global Health, Boston University

Sydney Rosen, M.P.A., is a Research Professor in the Department of Global Health and the Center for Global Health & Development of the Boston University School of Public Health and the co-director of the Health Economics and Epidemiology Research Office (HE2RO) of the Wits Health Consortium at the University of the Witwatersrand in Johannesburg, South Africa. In collaboration with HE2RO and colleagues at BUSPH, she leads an interdisciplinary team that is carrying out a set of studies on the effectiveness, costs, and benefits of HIV/AIDS care and treatment interventions. She has also worked on other applied economics projects at the Center, including research on the economics of tuberculosis, antimicrobial resistance, malaria prevention and treatment, and air pollution. Her technical training is in public policy analysis and applied economics. She came to the Center in 2001 from the Health Office of the former Harvard Institute for International Development (HIID). Before joining the staff of the Health Office, she managed a set of HIID environmental policy projects in the former Soviet Union. She is also the co-founder and former executive director of WorldTeach, Inc., a nonprofit organization that places volunteer teachers in developing countries. She holds a B.A. from Harvard University and a master’s degree from the Kennedy School of Government at Harvard.

HIV 'test and treat' strategy can save lives -- but it needs to be easier for patients to start treatment

May 19, 2016 07:05 am UTC| Insights & Views Health

The human immunodeficiency virus (HIV) continues to take a tremendous toll on human health, with 37 million people infected and 1.2 million deaths worldwide in 2014. In sub-Saharan Africa, where the HIV epidemic has been...

Economy

Asian Markets Quiet as Japan Gains on BOJ Decision; Australia Eyes Rate Cut

Most Asian stock markets were closed Thursday due to the Labor Day holiday, with trading volumes remaining low. However, Japanese shares advanced after the Bank of Japan (BOJ) left interest rates unchanged at 0.5%, as...

Australia’s Gold Rush to U.S. Turns Trade Deficit into Surplus

Australia recorded its strongest three-month export performance to the United States, driven largely by a surge in gold shipments amid President Donald Trumps tariff policies. According to the Australian Bureau of...

Dollar Stabilizes Amid Trade War Easing Hopes and Yen Waits on BOJ Decision

The U.S. dollar held steady on Thursday, shrugging off weak domestic data as markets turned hopeful over signs of easing global trade tensions. Despite suffering its steepest monthly decline in over two years through...

US Stock Futures Surge as Microsoft and Meta Earnings Beat Forecasts

U.S. stock futures rose sharply Wednesday night, driven by strong earnings reports from tech giants Microsoft and Meta Platforms. This positive momentum came after a choppy regular session where Wall Street posted modest...

Gold Slips on Eased Tariff Fears, Eyes Key U.S. Economic Data

Gold prices extended their decline during Asian trading on Wednesday as easing U.S. auto tariffs and positive trade signals reduced safe-haven demand. President Donald Trump signed two orders offering tax credits and...

Politics

Kamala Harris Slams Trump’s Economic Policies in Major Political Comeback

Former U.S. Vice President Kamala Harris issued a strong rebuke of President Donald Trump on Wednesday, calling his economic agenda the greatest man-made economic crisis in modern presidential history. Speaking in the San...

Medvedev Slams U.S.-Ukraine Minerals Deal as Trump Leverages Military Aid

Senior Russian official Dmitry Medvedev criticized a new U.S.-Ukraine minerals agreement, claiming it forces Kyiv to pay for future U.S. military aid with natural resources. The deal, signed in Washington, grants the U.S....

Senate Deadlocked on Tariff Rollback as U.S. Economy Shrinks

The U.S. Senate voted 49-49 on Wednesday, failing to pass a resolution aimed at reversing President Donald Trumps sweeping tariffs. The tie vote came just hours after federal data revealed that the U.S. economy contracted...

U.S. Warns Iran Over Houthi Support Amid Ongoing Nuclear Talks

U.S. Defense Secretary Pete Hegseth issued a stern warning to Iran on Wednesday over its support for Yemens Houthi rebels, even as indirect nuclear negotiations between the two nations continue. Speaking via X (formerly...

Singapore PM Urges Support for Trusted Team Ahead of May 3 Election

Singapore Prime Minister Lawrence Wong has urged voters to re-elect his cabinet in the May 3 general election, emphasizing the need for experienced leaders with strong ties to both the U.S. and China. Addressing 1.4...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Xiaomi Unveils MiMo AI Model, Shares Surge 5% on Breakthrough Launch

Xiaomi Corp (HK:1810) launched its first open-source large language model, MiMo, on Wednesday, marking its official entry into the competitive artificial intelligence space. The debut sent Xiaomis Hong Kong-listed shares...

OpenAI Rolls Back GPT-4o Update After User Backlash Over "Sycophantic" Behavior

OpenAI has rolled back a recent update to its GPT-4o model used in ChatGPT, following widespread criticism from users who found the AI assistant excessively flattering and overly agreeable. The company announced Tuesday...

TSMC Expands U.S. Chip Production With Third Arizona Fab and $100B Investment Boost

Taiwan Semiconductor Manufacturing Co. (NYSE:TSM), the worlds largest contract chipmaker, has officially broken ground on its third semiconductor fabrication plant in Phoenix, Arizona. This marks a major milestone in the...

Meta Launches Standalone AI App to Compete with OpenAI and Google

Meta Platforms (NASDAQ:META) has released a standalone app for its Meta AI assistant, marking a significant step to boost its presence in the rapidly evolving AI market. Previously accessible only through Metas main...

Alibaba Launches Qwen 3 AI Model Amid Intensifying China Tech Competition

Chinese tech giant Alibaba Group (NYSE:BABA) unveiled Qwen 3 on Tuesday, a next-generation AI model featuring hybrid reasoning capabilities aimed at boosting performance and adaptability. The move underscores Alibabas...